Published: Jan. 1, 2024
Language: Английский
Published: Jan. 1, 2024
Language: Английский
Journal of Molecular Liquids, Journal Year: 2024, Volume and Issue: 410, P. 125558 - 125558
Published: July 18, 2024
Language: Английский
Citations
30Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(9), P. 7406 - 7430
Published: April 20, 2024
A dual-targeting approach is predicted to yield better cancer therapy outcomes. Consequently, a series of coumarin-based thiazoles (5a–h, 6, and 7a–e) were designed constructed as potential carbonic anhydrase (CA) VEGFR-2 suppressors. The inhibitory actions the target compounds assessed against CA isoforms IX VEGFR-2. assay results showed that 5a, 5d, 5e can effectively inhibit both targets. cytotoxic effects tested on pancreatic, breast, prostate cells (PANC1, MCF7, PC3). Further mechanistic investigation disclosed ability interrupt PANC1 cell progression in S stage by triggering apoptotic cascade, seen increased levels caspases 3, 9, BAX, alongside Bcl-2 decline. Moreover, vivo efficacy compound an antitumor agent was evaluated. Also, molecular docking dynamics displayed distinctive interactions between binding pockets.
Language: Английский
Citations
15European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 274, P. 116527 - 116527
Published: May 24, 2024
Language: Английский
Citations
15Drug Development Research, Journal Year: 2024, Volume and Issue: 85(4)
Published: June 1, 2024
Abstract A new series of quinoxaline‐sulfonamide derivatives 3 – 12 were synthesized using fragment‐based drug design by reaction quinoxaline sulfonyl chloride (QSC) with different amines and hydrazines. The evaluated for antidiabetic anti‐Alzheimer's potential against α‐glucosidase, α‐amylase, acetylcholinesterase enzymes. These showed good to moderate potency α‐amylase α‐glucosidase inhibitory percentages between 24.34 ± 0.01%–63.09 0.02% 28.95 0.04%–75.36 0.01%, respectively. Surprisingly, bis ‐sulfonamide derivative 4 revealed the most potent activity 75.36 0.01% 63.09 α ‐glucosidase compared acarbose (IP = 57.79 67.33 0.01%), Moreover, exhibited as a minute decline from compound 44.93 38.95 0.01%. Additionally, in vitro designed weak activity. Still, sulfonamide‐quinoxaline emerged active member percentage 41.92 donepezil 67.27 0.60%). DFT calculations, docking simulation, target prediction, ADMET analysis performed discussed detail.
Language: Английский
Citations
10Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1309, P. 138148 - 138148
Published: March 26, 2024
Language: Английский
Citations
8Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1314, P. 138798 - 138798
Published: May 30, 2024
Language: Английский
Citations
8International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 140462 - 140462
Published: Jan. 1, 2025
Language: Английский
Citations
1International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 279, P. 135010 - 135010
Published: Aug. 26, 2024
Language: Английский
Citations
7European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 275, P. 116589 - 116589
Published: June 12, 2024
Language: Английский
Citations
6Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 153, P. 107843 - 107843
Published: Sept. 24, 2024
Language: Английский
Citations
5